DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Fabrazyme (Agalsidase Beta) - Deafness Unilateral - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Deafness Unilateral (8)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Fabrazyme (Agalsidase Beta) where reactions include deafness unilateral. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Fabrazyme side effects in male

Reported by a physician from Japan on 2012-08-06

Patient: male, weighing 67.0 kg (147.4 pounds)

Reactions: Deafness Unilateral

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fabrazyme
    Dosage: 70 mg, q4w
    Start date: 2009-11-12
    End date: 2010-06-23

Fabrazyme
    Dosage: 1.0 mg/kg, q2w
    Start date: 2006-08-08
    End date: 2009-10-29

Fabrazyme
    Dosage: 35 mg, q2w
    Start date: 2010-07-07
    End date: 2010-11-10

Fabrazyme
    Dosage: 50 mg, q2w
    Indication: Fabry's Disease
    Start date: 2010-12-08

Other drugs received by patient: Metoclopramide; Loxoprofen Sodium; Bucladesine Sodium; Clostridium Butyricum; Benzalkonium Chloride; Teprenone; Lidocaine Hydrochloride; Ifenprodil Tartrate; Mecobalamin; Sulfadiazine



Possible Fabrazyme side effects in male

Reported by a physician from Japan on 2012-07-27

Patient: male, weighing 67.0 kg (147.4 pounds)

Reactions: Deafness Unilateral

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fabrazyme
    Dosage: 70 mg, q4w
    Start date: 2009-11-12
    End date: 2010-06-23

Fabrazyme
    Dosage: 50 mg, q2w
    Indication: Fabry's Disease
    Start date: 2010-12-08

Fabrazyme
    Dosage: 35 mg, q2w
    Start date: 2010-07-07
    End date: 2010-11-10

Fabrazyme
    Dosage: 1.0 mg/kg, q2w
    Start date: 2006-08-08
    End date: 2009-10-29

Other drugs received by patient: Metoclopramide; Mecobalamin; Teprenone; Bucladesine Sodium; Lidocaine Hydrochloride; Ifenprodil Tartrate; Sulfadiazine; Loxoprofen Sodium; Benzalkonium Chloride; Clostridium Butyricum



Possible Fabrazyme side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-05

Patient: male, weighing 82.0 kg (180.4 pounds)

Reactions: Migraine, Deafness Unilateral

Drug(s) suspected as cause:
Fabrazyme



Possible Fabrazyme side effects in male

Reported by a physician from Japan on 2012-06-08

Patient: male, weighing 67.0 kg (147.4 pounds)

Reactions: Deafness Unilateral

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fabrazyme
    Dosage: 35 mg, q2w
    Start date: 2010-07-07
    End date: 2010-11-10

Fabrazyme
    Dosage: 50 mg, q2w
    Indication: Fabry's Disease
    Start date: 2010-12-08

Fabrazyme
    Dosage: 70 mg, q4w
    Start date: 2009-11-12
    End date: 2010-06-23

Fabrazyme
    Dosage: 1.0 mg/kg, q2w
    Start date: 2006-08-08
    End date: 2009-10-29

Other drugs received by patient: Sulfadiazine; Lidocaine HCL; Ifenprodil Tartrate; Benzalkonium Chloride; Loxoprofen Sodium; Metoclopramide; Clostridium Butyricum; Bucladesine Sodium; Teprenone; Mecobalamin



Possible Fabrazyme side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-18

Patient: male, weighing 82.0 kg (180.4 pounds)

Reactions: Migraine, Deafness Unilateral, Cognitive Disorder, Verbigeration

Drug(s) suspected as cause:
Fabrazyme



Possible Fabrazyme side effects in male

Reported by a physician from Japan on 2012-04-11

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: Deafness Unilateral

Drug(s) suspected as cause:
Fabrazyme
    Dosage: 0 mg, q4w
    Start date: 2011-06-01

Fabrazyme
    Dosage: 65 mg, q2w
    Start date: 2010-05-01

Fabrazyme
    Dosage: 1 mg/kg, q2w
    Indication: Fabry's Disease
    Start date: 2011-07-01

Fabrazyme
    Dosage: 35 mg, q2w
    Start date: 2010-11-01

Fabrazyme
    Dosage: 65 mg, q2w
    Start date: 2010-12-01

Fabrazyme
    Dosage: 35 mg, q4w
    Start date: 2009-11-01

Fabrazyme
    Dosage: 65 mg, q4w
    Start date: 2010-10-01

Fabrazyme
    Dosage: 55 mg, q2w
    Start date: 2012-02-01

Fabrazyme
    Dosage: 35 mg, q4w
    Start date: 2010-08-01



Possible Fabrazyme side effects in male

Reported by a physician from Japan on 2012-03-19

Patient: male, weighing 67.0 kg (147.4 pounds)

Reactions: Deafness Unilateral

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fabrazyme
    Dosage: 1.0 mg/kg, q2w
    Start date: 2006-08-08
    End date: 2009-10-29

Fabrazyme
    Dosage: 50 mg, q2w
    Indication: Fabry's Disease
    Start date: 2010-12-08

Fabrazyme
    Dosage: 70 mg, q4w
    Start date: 2009-11-12
    End date: 2010-06-23

Fabrazyme
    Dosage: 35 mg, q2w
    Start date: 2010-07-07
    End date: 2010-11-10

Other drugs received by patient: Sulfadiazine Ointment; Loxoprofen Sodium; Ifenprodil Tartrate; Mecobalamin; Lidocaine HCL; Metoclopramide; Benzalkonium Chloride; Clostridium Butyricum; Teprenone; Bucladesine Sodium



Possible Fabrazyme side effects in 38 year old male

Reported by a consumer/non-health professional from United States on 2011-11-09

Patient: 38 year old male

Reactions: Deafness Unilateral

Drug(s) suspected as cause:
Fabrazyme

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017